Andreas Halvorsen - Viking Global Investors
Holding/activity history for Editas Medicine Inc (EDIT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q3 | 0 | 0.00 | Sell 100.00% | 0.05 | SEC | ||
| 2020 Q2 | 413,000 | 0.05 | Reduce 19.36% | <0.01 | $29.58 | $12,217,000 | SEC |
| 2020 Q1 | 512,179 | 0.05 | Reduce 30.16% | 0.03 | $19.83 | $10,157,000 | SEC |
| 2019 Q4 | 733,401 | 0.10 | $29.61 | $21,716,000 | SEC | ||
| 2019 Q3 | 733,401 | 0.09 | Reduce 21.26% | 0.02 | $22.74 | $16,678,000 | SEC |
| 2019 Q2 | 931,401 | 0.10 | $24.74 | $23,043,000 | SEC | ||
| 2019 Q1 | 931,401 | 0.13 | $24.45 | $22,773,000 | SEC | ||
| 2018 Q4 | 931,401 | 0.12 | $22.75 | $21,189,000 | SEC | ||
| 2018 Q3 | 931,401 | 0.17 | $31.82 | $29,637,000 | SEC | ||
| 2018 Q2 | 931,401 | 0.20 | Reduce 10.04% | 0.02 | $35.83 | $33,372,000 | SEC |
| 2018 Q1 | 1,035,304 | 0.21 | Reduce 39.43% | 0.13 | $33.15 | $34,320,000 | SEC |
| 2017 Q4 | 1,709,401 | 0.33 | $30.73 | $52,530,000 | SEC | ||
| 2017 Q3 | 1,709,401 | 0.28 | $24.01 | $41,043,000 | SEC | ||
| 2017 Q2 | 1,709,401 | 0.20 | $16.78 | $28,684,000 | SEC | ||
| 2017 Q1 | 1,709,401 | 0.17 | $22.32 | $38,154,000 | SEC | ||
| 2016 Q4 | 1,709,401 | 0.13 | $16.23 | $27,744,000 | SEC | ||
| 2016 Q3 | 1,709,401 | 0.10 | $13.48 | $23,043,000 | SEC | ||
| 2016 Q2 | 1,709,401 | 0.18 | Reduce 19.95% | 0.07 | $24.40 | $41,709,000 | SEC |
| 2016 Q1 | 2,135,523 | 0.33 | Buy | 0.33 | $34.54 | $73,761,000 | SEC |